Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers

24 Feb 2022

Abstract excerpt

PURPOSE: Precision medicine approaches, including germline pharmacogenetics (PGx) and management of drug-drug interactions (DDIs), are likely to benefit patients with advanced cancer who are frequently prescribed multiple concomitant medications to treat cancer and associated conditions. Our objective was to assess the potential opportunities for PGx and DDI management within a cohort of adults with advanced...

Topics

Join the communities discussing this publication.

Colorectal Cancer Treatments and Studies
Pain Management and Opioid Use
Pharmacogenetics and Drug Metabolism

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35201852
DOI: 10.1200/po.21.00312

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid CancersPMID 35201852Read ↗

CLINICAL OPPORTUNITIES FOR GERMLINE PHARMACOGENETICS AND MANAGEMENT OF DRUG-DRUG INTERACTIONS IN PATIENTS WITH ADVANCED SOLID CANCERSSemantic proximity Read ↗

Germline oncopharmacogenetics, a promising field in cancer therapy.Semantic proximity Read ↗

Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision Oncology.Semantic proximity Read ↗

Modern developments in germline pharmacogenomics for oncology prescribingSemantic proximity Read ↗

Pharmacogenomics in the clinic.Semantic proximity Read ↗

Germline genetic variants with implications for disease risk and therapeutic outcomes.Semantic proximity Read ↗

Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.Semantic proximity Read ↗

Pharmacogenomics: An evolving clinical tool for precision medicine.Semantic proximity Read ↗

Germline pharmacogenomics in oncology: decoding the patient for targeting therapy.Semantic proximity Read ↗

Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.Semantic proximity Read ↗

Use of Pharmacogenetic Drugs by the Dutch PopulationSemantic proximity Read ↗

How to Transition from Single‐Gene Pharmacogenetic Testing to Preemptive Panel‐Based Testing: A TutorialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.